{"id":28770,"date":"2023-12-05T19:36:16","date_gmt":"2023-12-05T19:36:16","guid":{"rendered":"https:\/\/sbpt.org.br\/portal\/?p=28770"},"modified":"2023-12-05T19:36:16","modified_gmt":"2023-12-05T19:36:16","slug":"anvisa-aprova-vacina-contra-virus-sincicial-respiratorio","status":"publish","type":"post","link":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/","title":{"rendered":"Anvisa aprova vacina contra V\u00edrus Sincicial Respirat\u00f3rio"},"content":{"rendered":"\n<p>Nesta segunda-feira (04\/12), a Anvisa aprovou o registro da Arexvy, a primeira vacina contra o V\u00edrus Sincicial Respirat\u00f3rio (VSR) em adultos com 60 anos de idade ou mais.<\/p>\n<p>Classificado como o terceiro v\u00edrus mais prevalente em infec\u00e7\u00f5es respirat\u00f3rias em idosos, o VCR \u00e9 o principal v\u00edrus causador da bronquiolite e tem causado um impacto significativo na sa\u00fade dessa popula\u00e7\u00e3o.<\/p>\n<p>Al\u00e9m disso, \u00e9 respons\u00e1vel por exacerba\u00e7\u00f5es de patologias respirat\u00f3rias cr\u00f4nicas, com taxas de morbidade e mortalidade entre os idosos que podem ser maiores que as da Influenza.<\/p>\n<p>Uma meta-an\u00e1lise recente destacou que 5,2 milh\u00f5es de casos de VSR, em 2019, ocorreram em pa\u00edses de alta renda, entre adultos com 60 anos ou mais, resultando em 470 mil hospitaliza\u00e7\u00f5es e 33 mil mortes hospitalares.<\/p>\n<p>No Brasil, a letalidade associada \u00e0 s\u00edndrome respirat\u00f3ria aguda grave por VSR em pacientes com 60 anos ou mais \u00e9 de aproximadamente 19%, conforme o Informe da Vigil\u00e2ncia de S\u00edndromes Gripais, de 21 de novembro de 2023.<\/p>\n<p>A infec\u00e7\u00e3o natural pelo VSR geralmente resulta em imunidade incompleta, permitindo infec\u00e7\u00f5es sintom\u00e1ticas recorrentes ao longo da vida. O envelhecimento do sistema imunol\u00f3gico, conhecido como imunossenesc\u00eancia, aumenta ainda mais o risco de complica\u00e7\u00f5es graves ap\u00f3s a infec\u00e7\u00e3o por VSR, principalmente em adultos com comorbidades subjacentes.<\/p>\n<p>Aplicada de forma intramuscular, em dose \u00fanica, a vacina promete oferecer esperan\u00e7a e prote\u00e7\u00e3o para os brasileiros mais velhos, mesmo aqueles com diferentes graus de fragilidade e comorbidades.<\/p>\n","protected":false},"excerpt":{"rendered":"Nesta segunda-feira (04\/12), a Anvisa aprovou o registro da Arexvy, a primeira vacina contra o V\u00edrus Sincicial Respirat\u00f3rio (VSR) \u2013 o principal v\u00edrus causador da bronquiolite \u2013 em adultos com 60 anos de idade ou mais.","protected":false},"author":4,"featured_media":18502,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ngg_post_thumbnail":0,"footnotes":""},"categories":[68],"tags":[],"class_list":["post-28770","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anvisa aprova vacina contra V\u00edrus Sincicial Respirat\u00f3rio - sbpt.org.br<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa aprova vacina contra V\u00edrus Sincicial Respirat\u00f3rio - sbpt.org.br\" \/>\n<meta property=\"og:description\" content=\"Nesta segunda-feira (04\/12), a Anvisa aprovou o registro da Arexvy, a primeira vacina contra o V\u00edrus Sincicial Respirat\u00f3rio (VSR) - o principal v\u00edrus causador da bronquiolite - em adultos com 60 anos de idade ou mais.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/\" \/>\n<meta property=\"og:site_name\" content=\"sbpt.org.br\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pneumosbpt\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-05T19:36:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/01\/vacina.png\" \/>\n\t<meta property=\"og:image:width\" content=\"350\" \/>\n\t<meta property=\"og:image:height\" content=\"255\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ana Cecilia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:site\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ana Cecilia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\\\/\"},\"author\":{\"name\":\"Ana Cecilia\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/16420206caad8c0e363b70415d3f41e8\"},\"headline\":\"Anvisa aprova vacina contra V\u00edrus Sincicial Respirat\u00f3rio\",\"datePublished\":\"2023-12-05T19:36:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\\\/\"},\"wordCount\":257,\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/vacina.png\",\"articleSection\":[\"Not\u00edcias\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\\\/\",\"name\":\"Anvisa aprova vacina contra V\u00edrus Sincicial Respirat\u00f3rio - sbpt.org.br\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/vacina.png\",\"datePublished\":\"2023-12-05T19:36:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/vacina.png\",\"contentUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/vacina.png\",\"width\":350,\"height\":255},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa aprova vacina contra V\u00edrus Sincicial Respirat\u00f3rio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"name\":\"sbpt.org.br\",\"description\":\"Sociedade Brasileira de Pneumologia e Tisiologia\",\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"alternateName\":\"SBPT\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\",\"name\":\"sbpt.org.br\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"contentUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"width\":512,\"height\":512,\"caption\":\"sbpt.org.br\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pneumosbpt\",\"https:\\\/\\\/x.com\\\/pneumosbpt\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/socbraspneumol\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/16420206caad8c0e363b70415d3f41e8\",\"name\":\"Ana Cecilia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dbfc43f278fd8989d8e378cec64d1e30e66ca6714d974b3e52a2d8d5f3c77c57?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dbfc43f278fd8989d8e378cec64d1e30e66ca6714d974b3e52a2d8d5f3c77c57?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dbfc43f278fd8989d8e378cec64d1e30e66ca6714d974b3e52a2d8d5f3c77c57?s=96&d=mm&r=g\",\"caption\":\"Ana Cecilia\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa aprova vacina contra V\u00edrus Sincicial Respirat\u00f3rio - sbpt.org.br","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa aprova vacina contra V\u00edrus Sincicial Respirat\u00f3rio - sbpt.org.br","og_description":"Nesta segunda-feira (04\/12), a Anvisa aprovou o registro da Arexvy, a primeira vacina contra o V\u00edrus Sincicial Respirat\u00f3rio (VSR) - o principal v\u00edrus causador da bronquiolite - em adultos com 60 anos de idade ou mais.","og_url":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/","og_site_name":"sbpt.org.br","article_publisher":"https:\/\/www.facebook.com\/pneumosbpt","article_published_time":"2023-12-05T19:36:16+00:00","og_image":[{"width":350,"height":255,"url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/01\/vacina.png","type":"image\/png"}],"author":"Ana Cecilia","twitter_card":"summary_large_image","twitter_creator":"@pneumosbpt","twitter_site":"@pneumosbpt","twitter_misc":{"Escrito por":"Ana Cecilia","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/#article","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/"},"author":{"name":"Ana Cecilia","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/16420206caad8c0e363b70415d3f41e8"},"headline":"Anvisa aprova vacina contra V\u00edrus Sincicial Respirat\u00f3rio","datePublished":"2023-12-05T19:36:16+00:00","mainEntityOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/"},"wordCount":257,"publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/#primaryimage"},"thumbnailUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/01\/vacina.png","articleSection":["Not\u00edcias"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/","url":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/","name":"Anvisa aprova vacina contra V\u00edrus Sincicial Respirat\u00f3rio - sbpt.org.br","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/#primaryimage"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/#primaryimage"},"thumbnailUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/01\/vacina.png","datePublished":"2023-12-05T19:36:16+00:00","breadcrumb":{"@id":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/#primaryimage","url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/01\/vacina.png","contentUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/01\/vacina.png","width":350,"height":255},{"@type":"BreadcrumbList","@id":"https:\/\/sbpt.org.br\/portal\/anvisa-aprova-vacina-contra-virus-sincicial-respiratorio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sbpt.org.br\/portal\/"},{"@type":"ListItem","position":2,"name":"Anvisa aprova vacina contra V\u00edrus Sincicial Respirat\u00f3rio"}]},{"@type":"WebSite","@id":"https:\/\/sbpt.org.br\/portal\/#website","url":"https:\/\/sbpt.org.br\/portal\/","name":"sbpt.org.br","description":"Sociedade Brasileira de Pneumologia e Tisiologia","publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"alternateName":"SBPT","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sbpt.org.br\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/sbpt.org.br\/portal\/#organization","name":"sbpt.org.br","url":"https:\/\/sbpt.org.br\/portal\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/","url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","contentUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","width":512,"height":512,"caption":"sbpt.org.br"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pneumosbpt","https:\/\/x.com\/pneumosbpt","https:\/\/www.linkedin.com\/company\/pneumosbpt\/","https:\/\/www.instagram.com\/pneumosbpt\/","https:\/\/www.youtube.com\/user\/socbraspneumol"]},{"@type":"Person","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/16420206caad8c0e363b70415d3f41e8","name":"Ana Cecilia","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/dbfc43f278fd8989d8e378cec64d1e30e66ca6714d974b3e52a2d8d5f3c77c57?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/dbfc43f278fd8989d8e378cec64d1e30e66ca6714d974b3e52a2d8d5f3c77c57?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dbfc43f278fd8989d8e378cec64d1e30e66ca6714d974b3e52a2d8d5f3c77c57?s=96&d=mm&r=g","caption":"Ana Cecilia"}}]}},"_links":{"self":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/28770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/comments?post=28770"}],"version-history":[{"count":0,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/28770\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media\/18502"}],"wp:attachment":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media?parent=28770"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/categories?post=28770"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/tags?post=28770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}